| 05/06/26 | 07:00:03 | 5 Jun 2026 | | Notice of AGM |
| 29/05/26 | 09:18:29 | 29 May 2026 | | Grant of Options and Extension of Warrant Term |
| 30/04/26 | 16:04:40 | 30 Apr 2026 | | Final Results |
| 28/04/26 | 07:00:06 | 28 Apr 2026 | | Institutional Fundraise |
| 14/04/26 | 07:00:06 | 14 Apr 2026 | | Annual IND Report with FDA |
| 31/03/26 | 13:22:00 | 31 Mar 2026 | | Tech Transfer Completion and Clinical Trial Update |
| 27/02/26 | 08:10:00 | 27 Feb 2026 | | Total Voting Rights |
| 24/02/26 | 07:00:08 | 24 Feb 2026 | | Holding(s) in Company |
| 23/02/26 | 07:00:11 | 23 Feb 2026 | | Exercise of Warrants and Issue of Equity |
| 10/02/26 | 15:52:09 | 10 Feb 2026 | | Issue of Equity - Correction |
| 10/02/26 | 07:00:06 | 10 Feb 2026 | | Issue of Equity |
| 30/01/26 | 07:00:02 | 30 Jan 2026 | | Total Voting Rights |
| 12/01/26 | 07:00:07 | 12 Jan 2026 | | Holding(s) in Company |
| 22/12/25 | 08:00:01 | 22 Dec 2025 | | Update on Admission of Shares |
| 18/12/25 | 07:00:04 | 18 Dec 2025 | | Issue of Equity |
| 08/12/25 | 12:48:24 | 8 Dec 2025 | | Holding(s) in Company |
| 28/11/25 | 07:00:01 | 28 Nov 2025 | | Total Voting Rights |
| 19/11/25 | 11:47:16 | 19 Nov 2025 | | Publication of Prospectus |
| 29/10/25 | 07:00:09 | 29 Oct 2025 | | Clinical Trial Update and Grant of Share Awards |
| 06/10/25 | 07:00:08 | 6 Oct 2025 | | Clearance to Initiate Pediatric Enrolment |
| 30/09/25 | 07:00:10 | 30 Sept 2025 | | Half-year Report |
| 30/09/25 | 07:00:03 | 30 Sept 2025 | | Total Voting Rights |
| 23/09/25 | 07:00:03 | 23 Sept 2025 | | Hemogenyx Signs Letter of Intent |
| 18/09/25 | 13:16:41 | 18 Sept 2025 | | Holding(s) in Company |
| 17/09/25 | 07:00:12 | 17 Sept 2025 | | Third Patient Safety |
| 11/09/25 | 07:00:17 | 11 Sept 2025 | | Invitation to Participate at DCNY Summit |
| 08/09/25 | 07:00:09 | 8 Sept 2025 | | Manufacturing Partnership with Made Scientific |
| 05/09/25 | 07:00:04 | 5 Sept 2025 | | Exercise of Warrants and Issue of Equity |
| 03/09/25 | 13:57:24 | 3 Sept 2025 | | Exercise of Warrants and Issue of Equity |
| 01/09/25 | 15:06:49 | 1 Sept 2025 | | Issue of convertible loan notes |
| 29/08/25 | 07:00:08 | 29 Aug 2025 | | Result of Audit Tender |
| 26/08/25 | 11:44:49 | 26 Aug 2025 | | Hemogenyx raises £570,000 and Director's Dealing |
| 15/08/25 | 07:00:10 | 15 Aug 2025 | | Third Patient Treated with HG-CT-1 CAR-T Therapy |
| 31/07/25 | 07:00:07 | 31 Jul 2025 | | Total Voting Rights |
| 29/07/25 | 08:00:00 | 29 Jul 2025 | | Placing to Raise £250,000 and Director’s Dealing |
| 16/07/25 | 07:00:02 | 16 Jul 2025 | | Hemogenyx Awarded Grant |
| 30/06/25 | 07:00:03 | 30 Jun 2025 | | Total Voting Rights |
| 17/06/25 | 07:00:02 | 17 Jun 2025 | | Clearance to Proceed with Pediatric Expansion |
| 03/06/25 | 14:02:15 | 3 Jun 2025 | | Placing to Raise £451,250 and Director’s Dealing |
| 03/06/25 | 07:00:09 | 3 Jun 2025 | | Second Patient Passes Initial Safety Tests |
| 30/05/25 | 15:14:31 | 30 May 2025 | | Total Voting Rights |
| 29/05/25 | 14:06:16 | 29 May 2025 | | Result of AGM |
| 14/05/25 | 07:00:08 | 14 May 2025 | | Pediatric Amendment to Clinical Protocol |
| 13/05/25 | 07:00:11 | 13 May 2025 | | AGM Correction |
| 08/05/25 | 07:00:06 | 8 May 2025 | | Placing to Raise £451,250 and Director’s Dealing |
| 02/05/25 | 16:24:14 | 2 May 2025 | | Notice of AGM |
| 02/05/25 | 07:00:04 | 2 May 2025 | | Second Patient Treated with HG-CT-1 CAR-T Therapy |
| 28/04/25 | 07:00:05 | 28 Apr 2025 | | Final Results |
| 03/04/25 | 07:00:11 | 3 Apr 2025 | | FDA Annual Report |
| 31/03/25 | 07:00:09 | 31 Mar 2025 | | Total Voting Rights |